Fig. 2From: Efficacy and safety of venetoclax combined with hypomethylating agents for relapse of acute myeloid leukemia and myelodysplastic syndrome post allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysisForest plot of pooled CR/CRi rates after treatmentBack to article page